UTHR
United Therapeutics Corporation
Stock
$541.70−29.68 (−5.19%)Close Oct 2, 2026
- Operating income, 2025
- $1.5B
- YoY, 2025
- +8.4%
- 5-year CAGR
- +20.2%
- 10-year CAGR
- +7.9%
Operating income
Operating income by fiscal year
| Period | Operating income | YoY |
|---|---|---|
| 2025 | $1.5B | +8.4% |
| 2024 | $1.4B | +16.2% |
| 2023 | $1.2B | +20.9% |
| 2022 | $980M | +76.2% |
| 2021 | $556M | −6.4% |
| 2020 | $594M | — |
| 2019 | −$188M | — |
| 2018 | $805M | −1.2% |
| 2017 | $815M | −23.2% |
| 2016 | $1.1B | +51.9% |
| 2015 | $699M | +29.7% |
| 2014 | $539M | +84.2% |
| 2013 | $292M | −30.6% |
| 2012 | $422M | +32.7% |
| 2011 | $318M | +85.5% |
| 2010 | $171M | +565.1% |
| 2009 | $26M | — |
| 2008 | −$82M | — |